Concerns/Issues about Results and/or Conclusions
- Resistance to apoptosis mediated by agonist Fas antibody in peripheral T-lymphocytes from Crohn’s disease patients at onset1/24/2022 0:00
- Aluminum enhances inflammation and decreases healing in experimental models of colitis1/24/2022 0:00
- Role of PPAR-g ligands in the course of experimental chronic inflammation of rats’ large intestine1/24/2022 0:00
- Effect of steroids on dysregulated human immune post-code system in erythema nodosum1/24/2022 0:00
- Impaired expression of PPARg in patients with ulcerative colitis is associated with a decreased intraepithelial steroidogenesis1/24/2022 0:00
- The effect of infliximab and adalimumab treatment on angiogenic factors levels in patients with inflammatory bowel disease (IBD)1/24/2022 0:00
- Lack of CRP response in patients with active Crohn’s disease is characterized by low IL-6 concentrations but not with genetic variants in the CRP gene1/24/2022 0:00
- Dysregulation of the myeloid cell response exacerbates acute colitis by impairing mucosal healing1/24/2022 0:00
- The Effect of COVID-19 Vaccination on Reducing the Risk of Infection, Hospitalization, and Death in Isfahan Province, Iran2/1/2022 0:00
- Immunomodulatory effect of Lactobacillus casei DN-1140001 antigens on development of dextran sodium sulphate induced colitis1/24/2022 0:00
- Colorectal carcinoma in ulcerative colitis: Is metilation status of the promotor region of SOX2 and PDX1 genes associated with neoplasia?1/24/2022 0:00
- Different mucosal expression of Th17 related genes in the small and large bowel of IBD patients1/24/2022 0:00
- Antibiotic treatment influences microbiota and tumor development in mouse model of colitis-associated carcinoma1/24/2022 0:00
- Interleukin 21 (IL-21) gene expression correlates with disease activity in patients with ulcerative colitis1/24/2022 0:00
- The role and source of IL17 and IL22 in intestinal inflammation1/24/2022 0:00
- Antagonist of PPAR-g receptor modulates rats’ colitis induced by TNBS1/24/2022 0:00
- The surface hydrophobicity of the colonic mucosa is reduced in ulcerative colitis1/24/2022 0:00
- Estrogen receptor-beta expression as a molecular prognostic marker of cancer progression in ulcerative colitis1/24/2022 0:00
- The inhibition of catalase (CAT) activity of peripheral white mononuclear cells (PWMC) in naïve Crohn’s disease (CD) patients depends on a down regulation of CAT-gene expression1/24/2022 0:00
- Immunohistochemical expression of FAS, p53, Ki67 and p16 in the mucosa of patients affected by long-standing ulcerative colitis1/24/2022 0:00
- Immunohistochemical evaluation of blood and lymphatic microvessels in colon of patients with ulcerative colitis (UC)1/24/2022 0:00
- Cell isolation and purification methods from endoscopic biopsy specimens1/24/2022 0:00
- Segmental intestinal perfusion as a short time rat model of inflammatory bowel diseases1/24/2022 0:00
- Impact of Crohn’s disease duration on health care resource utilization and comorbidity development1/24/2022 0:00
- Environmental risk factors for inflammatory bowel disease in a British co-twin control study1/24/2022 0:00
- Decreased activity of DNase I predisposes to immune-mediated complications in IBD patients treated by anti-TNFalpha agents1/24/2022 0:00
- Serum Lipopolysaccharide-binding protein (LBP), and soluble CD14 receptor (sCD14) are markers of disease activity in patients with Crohn’s disease1/24/2022 0:00
- The role of quantitative analysis (strain ratio) of transrectal endoscopic ultrasound (TRUS) elastography in inflammatory bowel disease (IBD)1/24/2022 0:00
- Identifying appropriate dichotomizing points for SES-CD to predict long-term clinical remission for adalimumab-treated patients with Crohn’s disease1/24/2022 0:00
- Circulating measurements of S100A12 are highly dependent on pre-analytical factors: Clinical consequences for the assessment of S10012 proteins in inflammatory bowel diseases1/24/2022 0:00
- Magnetic resonance enterography in the assessment of the disease activity in Crohn’s disease A retrospective study1/24/2022 0:00
- Faecal calprotectin is a cost-effective method of assessing activity of inflammatory bowel disease1/24/2022 0:00
- Is there any correlation between colonoscopy and calprotectin as predictive markers of early relapse in inflammatory bowel disease?1/24/2022 0:00
- Pregnancy outcome in women with inflammatory bowel disease according to the activity of the disease and the drug treatment1/24/2022 0:00
- Faecal calprotectin levels as a marker of activity in Egyptian inflammatory bowel disease patients1/24/2022 0:00
- Should the development of perianal disease change disease diagnosis in patients with ulcerative colitis?1/24/2022 0:00
- Symptoms related cancer risk in patients undergoing bowel surgery for Crohn’s disease1/24/2022 0:00
- Entero-CT vs small intestine contrast ultrasonography (SICUS) in assessing ileal lesions in Crohn’s disease: A prospective longitudinal study after ileo-colonic resection1/24/2022 0:00
- Accuracy of abdominal ultrasound in the assessment of inflammatory activity in patients with ulcerative colitis1/24/2022 0:00
- Kinetics of C-reactive protein (CRP) following maintenance infliximab treatment in Crohn’s disease identifies profiles of patients with better outcome1/24/2022 0:00
- Antiglycan antibodies in Greek patients with inflammatory bowel disease1/24/2022 0:00
- Evaluation of stricturing ileal Crohn’s disease by magnetic resonance and ileoscopy: Influence of disease duration and surgery1/24/2022 0:00
- Colonoscopic surveillance in ulcerative colitis: Are British Society of Gastroenterology guidelines being adhered to?1/24/2022 0:00
- Duration of Crohn’s disease affects mucosal healing in adalimumab-treated patients: Results from EXTEND1/24/2022 0:00
- Mucosal healing predicts long-term clinical benefits for adalimumab-treated patients with Crohn’s disease1/24/2022 0:00
- Inflammatory bowel disease-induced changes in circulating levels of a2-Heremans-Schmid Glycoprotein (Fetuin A)1/24/2022 0:00
- Inflammatory bowel disease in patients with primary sclerosing cholangitis: A distinct clinical, endoscopic and pathologic entity?1/24/2022 0:00
- Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity1/24/2022 0:00
- Adalimumab improves quality of life for Japanese patients with moderately to severely active Crohn’s disease1/24/2022 0:00
- Mucosal healing predicts quality-of-life benefits for adalimumab-treated patients with Crohn’s disease1/24/2022 0:00